GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration-Reference-Cited by-同舟云学术

GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration

Published:2017-02-10 Issue:1 Volume:8 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Skorska Anna,Müller Paula,Gaebel Ralf,Große Jana,Lemcke Heiko,Lux Cornelia A.,Bastian Manuela,Hausburg Frauke,Zarniko Nicole,Bubritzki Sandra,Ruch Ulrike,Tiedemann Gudrun,David Robert,Steinhoff Gustav

Funder

Federal Ministry of Education and Research Germany

FORUN Program of Rostock University Medical Cent

BMBF

DAMP Foundation

Deutsche Herzstiftung

State Mecklenburg-Western Pomerania with EU Structural Funds

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13287-016-0467-0.pdf

Reference42 articles.

1. Stamm C, Westphal B, Kleine H-D, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361(9351):45–6. doi: 10.1016/S0140-6736(03)12110-1 .

2. Henning RJ. Stem cells in cardiac repair. Future Cardiol. 2011;7(1):99–117. doi: 10.2217/fca.10.109 .

3. Da Silva JS, Hare JM. Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods Mol Biol. 2013;1037:145–63. doi: 10.1007/978-1-62703-505-7_8 .

4. Young PP, Schafer R. Cell-based therapies for cardiac disease: a cellular therapist’s perspective. Transfusion. 2015;55(2):441–51. doi: 10.1111/trf.12826 . quiz 440.

5. Stamm C, Kleine H-D, Choi Y-H, et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg. 2007;133(3):717–25. doi: 10.1016/j.jtcvs.2006.08.077 .

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell manufacturing landscape—Lessons from the past decade and considerations for early clinical development;Molecular Therapy - Methods & Clinical Development;2024-06

2. Cell Therapy in the Treatment of Coronary Heart Disease;International Journal of Molecular Sciences;2023-11-28

3. Engineered biomaterials in stem cell-based regenerative medicine;Life Medicine;2023-07-20

4. Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients;Gene Therapy;2021-04-19

5. Estimation of manufacturing development costs of cell-based therapies: a feasibility study;Cytotherapy;2021-02